scorecardresearch
Add as a preferred source on Google
Monday, April 20, 2026
TopicGLP-1

Topic: GLP-1

‘Price no challenge, mindset is’: Novo Nordisk eyes next-gen anti-obesity drugs as generics enter market

Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.

What happens when use of GLP-1 drugs is stopped? What UK researchers found on tracking patients for a yr

Semaglutide, active ingredient in popular weight-loss drugs, including Ozempic and Wegovy, belongs to the class of medications known as GLP-1 receptor agonists.

How GLP-1 ‘wonder drugs’ for diabetes & obesity also reduce risk of addiction to liquor, smoking & more

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

On Camera

India’s close encounters with Pakistan on Siachen

Pakistan's SSG team was not adequately provisioned for the inclement weather. If it managed to consolidate its position, the story of Siachen would have been different. 

Recovery of energy flows will be ‘gradual rather than immediate’ as Hormuz re-opens post ceasefire

The reopening of the Strait of Hormuz eases supply fears, but controlled shipping, slow output recovery, and high costs may delay oil flow normalisation for months.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.